Correction: miRNA proxy approach reveals hidden functions of glycosylation (Proceedings of the National Academy of Sciences of the United States of America (2015) 112, 23 (7327-7332) DOI: 10.1073/pnas.1502076112);MiRNA proxy approach reveals hidden functions of glycosylation

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 23, 2015, Pages 7327-7332

  Kurcon, Tomasz ^a   Liu, Zhongyin ^a   Paradkar, Anika V ^a   Vaiana, Christopher A ^a   Koppolu, Sujeethraj ^a   Agrawal, Praveen ^a   Mahal, Lara K ^a  

^a NEW YORK UNIVERSITY   (United States)

Author keywords

Epithelial to mesenchymal transition; Glycan regulation; Glycomics; MiR 200; TGF beta

Indexed keywords

(ALPHA N ACETYLNEURAMINYL 2,3 BETA GALACTOSYL 1,3) N ACETYLGALACTOSAMINIDE ALPHA 2,6 SIALYLTRANSFERASE 5; BETA 1,3 GLUCOSYLTRANSFERASE; BETA GALACTOSIDE ALPHA 2,3 SIALYLTRANSFERASE 5; GLUCOSYLTRANSFERASE; GLYCAN; MICRORNA 200; SIALYLTRANSFERASE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; MICRORNA; TRANSFERASE;

ARTICLE; BIOLOGICAL ACTIVITY; ENZYME GLYCOSYLATION; ENZYME STRUCTURE; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; GENE SILENCING; GENETICS; GLYCOSYLATION; METABOLISM; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; GENE SILENCING; GLYCOSYLATION; HUMANS; MICRORNAS; REAL-TIME POLYMERASE CHAIN REACTION; TRANSFERASES;

EID: 84931287664     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1512883112     Document Type: Erratum

References (48)

1. National Research Council (2012) Transforming Glycoscience: A Roadmap for the Future (National Academies, Washington, DC) p 191.
2. Freeze HH, Chong JX, Bamshad MJ, Ng BG (2014) Solving glycosylation disorders: Fundamental approaches reveal complicated pathways. Am J Hum Genet 94(2):161-175.
3. Inanloo Rahatloo K, et al. (2014) Mutation in ST6GALNAC5 identified in family with coronary artery disease. Sci Rep 4:3595.
4. Lencz T, et al. (2013) Genome-wide association study implicates NDST3 in schizophrenia and bipolar disorder. Nat Commun 4:2739.
5. Rakus JF, Mahal LK (2011) New technologies for glycomic analysis: Toward a systematic understanding of the glycome. Annu Rev Anal Chem (Palo Alto Calif) 4:367-392.
6. Fabian MR, Sonenberg N, Filipowicz W (2010) Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 79:351-379.
7. Kasper BT, Koppolu S, Mahal LK (2014) Insights into miRNA regulation of the human glycome. Biochem Biophys Res Commun 445(4):774-779.
8. Agrawal P, et al. (2014) Mapping posttranscriptional regulation of the human glycome uncovers microRNA defining the glycocode. Proc Natl Acad Sci USA 111(11):4338-4343.
9. Gaziel-Sovran A, et al. (2011) miR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis. Cancer Cell 20(1):104-118.
10. Kasza Z, et al. (2013) MicroRNA-24 suppression of N-deacetylase/N-sulfotransferase-1 (NDST1) reduces endothelial cell responsiveness to vascular endothelial growth factor A (VEGFA). J Biol Chem 288(36):25956-25963.
11. Pedersen ME, et al. (2013) An epidermal microRNA regulates neuronal migration through control of the cellular glycosylation state. Science 341(6152):1404-1408.
12. Bracken CP, et al. (2014) Genome-wide identification of miR-200 targets reveals a regulatory network controlling cell invasion. EMBO J 33(18):2040-2056.
13. Liu Q, et al. (2008) miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes. Nucleic Acids Res 36(16):5391-5404.
14. Thiery JP, Acloque H, Huang RY, Nieto MA (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139(5):871-890.
15. Brabletz S, Brabletz T (2010) The ZEB/miR-200 feedback loop-a motor of cellular plasticity in development and cancer? EMBO Rep 11(9):670-677.
16. Gregory PA, et al. (2008) The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10(5):593-601.
17. Park SM, Gaur AB, Lengyel E, Peter ME (2008) The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 22(7):894-907.
18. Betel D, Koppal A, Agius P, Sander C, Leslie C (2010) Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites. Genome Biol 11(8):R90.
19. Jurmeister S, et al. (2012) MicroRNA-200c represses migration and invasion of breast cancer cells by targeting actin-regulatory proteins FHOD1 and PPM1F. Mol Cell Biol 32(3):633-651.
20. Kanehisa M, Goto S (2000) KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res 28(1):27-30.
21. Hess D, Keusch JJ, Oberstein SA, Hennekam RC, Hofsteenge J (2008) Peters Plus syndrome is a new congenital disorder of glycosylation and involves defective Omicronglycosylation of thrombospondin type 1 repeats. J Biol Chem 283(12):7354-7360.
22. Boccuto L, et al. (2014) A mutation in a ganglioside biosynthetic enzyme, ST3GAL5, results in salt & pepper syndrome, a neurocutaneous disorder with altered glycolipid and glycoprotein glycosylation. Hum Mol Genet 23(2):418-433.
23. Simpson MA, et al. (2004) Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase. Nat Genet 36(11): 1225-1229.
24. Bos PD, et al. (2009) Genes that mediate breast cancer metastasis to the brain. Nature 459(7249):1005-1009.
25. Liang CC, Park AY, Guan JL (2007) In vitro scratch assay: A convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2(2):329-333.
26. Jessani N, et al. (2004) Carcinoma and stromal enzyme activity profiles associated with breast tumor growth in vivo. Proc Natl Acad Sci USA 101(38):13756-13761.
27. Gregory PA, et al. (2011) An autocrine TGF-beta/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition. Mol Biol Cell 22(10):1686-1698.
28. Liu J, et al. (2013) Suppression of SCARA5 by Snail1 is essential for EMT-associated cell migration of A549 cells. Oncogenesis 2:e73.
29. Nita-Lazar M, Rebustini I, Walker J, Kukuruzinska MA (2010) Hypoglycosylated E-cadherin promotes the assembly of tight junctions through the recruitment of PP2A to adherens junctions. Exp Cell Res 316(11):1871-1884.
30. Pinho SS, et al. (2012) Loss and recovery of Mgat3 and GnT-III Mediated E-cadherin N-glycosylation is a mechanism involved in epithelial-mesenchymal-epithelial transitions. PLoS ONE 7(3):e33191.
31. Freire-de-Lima L (2014) Sweet and sour: The impact of differential glycosylation in cancer cells undergoing epithelial-mesenchymal transition. Front Oncol 4:59.
32. Draghici S, Khatri P, Eklund AC, Szallasi Z (2006) Reliability and reproducibility issues in DNA microarray measurements. Trends Genet 22(2):101-109.
33. Nairn AV, et al. (2012) Regulation of glycan structures in murine embryonic stem cells: Combined transcript profiling of glycan-related genes and glycan structural analysis. J Biol Chem 287(45):37835-37856.
34. Schjoldager KT, Clausen H (2012) Site-specific protein O-glycosylation modulates proprotein processing - deciphering specific functions of the large polypeptide Gal-NAc-transferase gene family. Biochim Biophys Acta 1820(12):2079-2094.
35. Dalziel M, Crispin M, Scanlan CN, Zitzmann N, Dwek RA (2014) Emerging principles for the therapeutic exploitation of glycosylation. Science 343(6166):1235681.
36. Kim SJ, et al. (2013) Ganglioside GM3 participates in the TGF-β1-induced epithelial-mesenchymal transition of human lens epithelial cells. Biochem J 449(1):241-251.
37. Heinonen TY, Maki M (2009) Peters'-plus syndrome is a congenital disorder of glycosylation caused by a defect in the beta1,3-glucosyltransferase that modifies thrombospondin type 1 repeats. Ann Med 41(1):2-10.
38. Ittner LM, et al. (2005) Compound developmental eye disorders following inactivation of TGFbeta signaling in neural-crest stem cells. J Biol 4(3):11.
39. Kang P, Svoboda KK (2005) Epithelial-mesenchymal transformation during craniofacial development. J Dent Res 84(8):678-690.
40. Vasudevan D, Takeuchi H, Johar SS, Majerus E, Haltiwanger RS (2015) Peters plus syndrome mutations disrupt a noncanonical ER quality-control mechanism. Curr Biol 25(3):286-295.
41. Le Goff C, Cormier-Daire V (2012) From tall to short: The role of TGFβ signaling in growth and its disorders. Am J Med Genet C Semin Med Genet 160C(3):145-153.
42. Chen C, et al. (2014) Serum TGF-β1 and SMAD3 levels are closely associated with coronary artery disease. BMC Cardiovasc Disord 14:18.
43. Lan TH, Huang XQ, Tan HM (2013) Vascular fibrosis in atherosclerosis. Cardiovasc Pathol 22(5):401-407.
44. Gloster TM, Vocadlo DJ (2012) Developing inhibitors of glycan processing enzymes as tools for enabling glycobiology. Nat Chem Biol 8(8):683-694.
45. Hsu KL, Pilobello K, Krishnamoorthy L, Mahal LK (2011) Ratiometric lectin microarray analysis of the mammalian cell surface glycome. Methods Mol Biol 671:117-131.
46. Hsu KL, Gildersleeve JC, Mahal LK (2008) A simple strategy for the creation of a recombinant lectin microarray. Molecular BioSystems 4(6):654-662.
47. Pilobello KT, Agrawal P, Rouse R, Mahal LK (2013) Advances in lectin microarray technology: Optimized protocols for piezoelectric print conditions. Curr Protoc Chem Biol 5(1):1-23.
48. Batista BS, Eng WS, Pilobello KT, Hendricks-Munoz KD, Mahal LK (2011) Identification of a conserved glycan signature for microvesicles. J Proteome Res 10(10):4624-4633.